\
&
Contact us
Published on | 1 year ago
Programmes Agro-Food, EnvironmentThe co-funded European Biodiversity Partnership (Biodiversa+) has announced its upcoming new transnational call on “Biodiversity and transformative change”.
The call is planned to be officially launched on 10 September 2024.
An information webinar for potential applicants is scheduled on 24 September 2024, from 13:00 to 15:00 CEST.
For more information, please refer to the Biodiversa+ website: https://www.biodiversa.eu/2024/06/11/2024-2025-joint-call/
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.